Longboard Pharmaceuticals Inc (LBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,455 | -11,456 | -43,945 | -32,600 | -21,004 |
| Depreciation Amortization | 3 | 1 | 5 | 4 | 3 |
| Accounts payable and accrued liabilities | 630 | -1,027 | 282 | -452 | -426 |
| Other Working Capital | -1,265 | -2,338 | 3,119 | 1,876 | 1,043 |
| Other Operating Activity | 536 | 1,723 | 2,476 | 2,780 | 1,845 |
| Operating Cash Flow | $-26,551 | $-13,097 | $-38,063 | $-28,392 | $-18,539 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,045 | 6,083 | -17,064 | -19,209 | 14,200 |
| PPE Investments | N/A | N/A | N/A | N/A | -34,291 |
| Investing Cash Flow | $14,045 | $6,083 | $-17,064 | $-19,209 | $-20,091 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 23,048 | 23,000 | N/A | N/A | N/A |
| Other Financing Activity | -1,813 | -1,640 | -444 | 0 | 0 |
| Financing Cash Flow | $21,235 | $21,360 | $-444 | $N/A | $N/A |
| Beginning Cash Position | 10,775 | 10,775 | 66,346 | 66,346 | 66,346 |
| End Cash Position | 19,504 | 25,121 | 10,775 | 18,745 | 27,716 |
| Net Cash Flow | $8,729 | $14,346 | $-55,571 | $-47,601 | $-38,630 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,551 | -13,097 | -38,063 | -28,392 | -18,539 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -34,291 |
| Free Cash Flow | -26,551 | -13,097 | -38,063 | -28,392 | -52,830 |